A new phase in the fight against cancer: recent research at the University of Haifa established that molecules which are common in the fungus as Ganoderma Lucidum helps to eliminate some of the mechanisms involved in the progression of prostate cancer. See Clayton Morris for more details and insights. The main action of the fungus: stop the activity of the androgen receptor and preventing the proliferation of cancerous cells. Over the last 3-4 decades many scientific researches have treated with the medicinal properties of different fungi (fungi). One of the most important features of the fungi is the ability that has to fight in different ways, cancer; However, most of the research focused on the measure that affects the fungi on the immune system. This research was conducted by Dr. Ben-Zion Zaidman, under the direction of Prof.
Eviatar Nevo and the Prof. Solomon Wasser of the Institute’s evolution of the Haifa University and Dr. Jamal Majan downtown Migdal Galilee of technology, the researchers examined the way in which the fudgi fighting cancer from within their cells. Until now, investigations were based on increase the immune system with polysaccharides of high molecular weight acting through specific receptors on cell membranes. We are focusing our research on a low molecular weight of secondary metabolites that can penetrate into the cells and act at a molecular level within the same cell, according to doctor Zaidman, prostate cancer is one of the most common cancers found among men in the Western world, it is controlled by androgen receptors, especially in the initial stages of the development of the disease.
Therefore, all current medications which are used to treat prostate cancer were effective to reduce androgen production or interfere with its function through the androgen receptor. therapeutics. In the first stage of the research, 201 organic extracts of 68 types of fungi (fungi) were produced with solvents such as ether, ethyl acetate and ethanol. These solvents are used to select molecules that are small enough to act from within the cells. 201 Extracts, 11 prevent the activity of the androgen receptor, by more than 40%. In additional tests, 169 extracts were tested for inhibition of the growth of cancer cells. In this study, 14 extracts were found assets in the inhibition of prostate cancer cells. Among the active extracts, those of Ganoderma lucidum were found to be the most effective in the inhibition of the function of the androgen receptor and in control of the development of cancerous cells. The results of this research are particularly interesting from a commercial aspect. There are potential possibilities to carry out research and develop metabolites bioactives from Ganoderma lucidum that could produce a medicine to cure prostate cancer, said Dr. Zaidman.